




Searching News Database: Xeltis
HSMN NewsFeed - 29 Nov 2018
FDA Accepts Filing of New Estrogen-free Oral Contraceptive Developed by Exeltis
FDA Accepts Filing of New Estrogen-free Oral Contraceptive Developed by Exeltis
HSMN NewsFeed - 31 Aug 2017
U.S. FDA Approves Chemo Group's Benznidazole to Treat Children with Chagas Disease
U.S. FDA Approves Chemo Group's Benznidazole to Treat Children with Chagas Disease
HSMN NewsFeed - 17 May 2017
Xeltis' Technology for Natural Heart Valve Restoration Featured as the Future of Valve Therapy at EuroPCR
Xeltis' Technology for Natural Heart Valve Restoration Featured as the Future of Valve Therapy at EuroPCR
HSMN NewsFeed - 13 Apr 2017
RedHill Biopharma and IntelGenx Announce Marketing Approval of RIZAPORT(R) for Migraines in Luxembourg
RedHill Biopharma and IntelGenx Announce Marketing Approval of RIZAPORT(R) for Migraines in Luxembourg
HSMN NewsFeed - 17 Dec 2015
Xeltis Extends Series B Financing to €30M, Signing Off Transformational Year
Xeltis Extends Series B Financing to €30M, Signing Off Transformational Year
HSMN NewsFeed - 16 Dec 2013
Everett Laboratories Acquires Quinnova Pharmaceuticals to Diversify U.S. Pharmaceutical Presence
Everett Laboratories Acquires Quinnova Pharmaceuticals to Diversify U.S. Pharmaceutical Presence